Moneycontrol PRO
X

business

Ideas For Profit | Dr Reddy’s: India, China & Russia opportunity to offset US pricing worries?

Dr Reddy's stock is trading at 9.7x FY24e EV/EBITDA, which is at a discount to the median multiple for the sector. MC Pro believes steady traction in limited competition products and strong presence in emerging markets make the stock an accumulation candidate on declines. Watch the video to know about the key triggers and tailwinds for the company.

first published: May 20, 2022 05:47 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347